Infectious Disease Diagnostics Market is Expected to Reach $18,156.2 Million by 2019 - New Research Report by MarketsandMarkets
(PRWEB) January 25, 2015 -- The global IDD market report is segmented by product, application, technology, end user, and region. The immunodiagnostics and polymerase chain reaction technology segments accounted for the lion’s share of the global IDD market by technology, owing to growing need for advanced technologies for rapid diagnosis of infectious diseases.
Full Report @ http://www.marketsandmarkets.com/Market-Reports/infectious-disease-diagnostics-market-116764589.html
On the basis of application, the IDD market is categorized into the Hepatitis B, Hepatitis C, Human Immunodeficiency Virus (HIV), Tuberculosis (TB), Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG), human papillomavirus (HPV), methicillin-resistant Staphylococcus aureus (MRSA), and others (Influenza, Ebola, Typhoid, Malaria, and Dengue, among others). Hospital-acquired MRSA infections, human papillomavirus, and AIDS are expected to be new revenue pockets in the applications market. The rising prevalence of these diseases globally is the major factor driving the growth of the aforementioned markets.
For Report Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=116764589
On the basis of product, the IDD market is segmented into instruments, consumables (reagents and assays), and software & services. Among products, consumables are estimated to be the fastest-growing market owing to its growing adoption in emerging infectious disease diagnostics worldwide.
On the basis of end user, the market is segmented into hospital laboratories, reference labs, physician’s office labs, academics, and others (blood banks, local public health laboratories, home health agencies, nursing homes, point of care, self-testing). Hospital laboratories are expected to be the fastest-growing market in the forecast period. Owing to the complexity and highly specialized nature of diagnostic tests for infectious diseases, hospital laboratories are expected to grow at the fastest rate in the forecast period, from 2014 to 2019.
Ask for PDF Manual @ http://www.marketsandmarkets.com/pdfdownload.asp?id=116764589
From an insight perspective, this report focuses on qualitative data, market size, and the growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and related growth of various segments in the industry. It focuses on emerging and high-growth segments of the IDD market, high-growth regions, and initiatives of respective governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles offer basic views on key players in the IDD market and their product portfolios, recent developments, and key strategies adopted. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, approaches, R&D investments for innovations in products and technologies, and levels of output, in order to remain successful.
Browse Related Reports:
Allergy Diagnostics Market by Allergen Source (Food Allergens, Inhaled Allergens), Product (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) & by End User (Hospital, Diagnostic Laboratory) - Global Forecast to 2019
http://www.marketsandmarkets.com/Market-Reports/allergy-diagnostics-market-232871701.html
Point-Of-Care Diagnostics / Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
e-mail: [email protected]
Visit MarketsandMarkets Blog@ http://mnmblog.org/market-research/healthcare/healthcareit
Mr. Rohan, MarketsandMarkets, http://www.marketsandmarkets.com/, +91 9881155004, [email protected]
Share this article